Table 3 Estimates of completeness of each source (model 7)
Strata | Total | DOVIH | EPF | LaboVIH | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (95% CI) | N obs | Compl(%) | (95% CI) | N obs | Compl(%) | (95% CI) | N obs | Compl(%) | (95% CI) | N obs | Compl(%) | (95% CI) | |
Year of diagnosis | ||||||||||||||
2003 | 107 | (72.4;142.7) | 60 | 55.8 | (42.0:82.9) | 30 | 27.9 | (21.0;41.4) | 28 | 26.0 | (19.6:38.7) | 30 | 27.9 | (21.0;41.4) |
2004 | 99 | (68.9;129.4) | 59 | 59.5 | (45.6;85.7) | 35 | 35.3 | (27.0;50.8) | 32 | 32.3 | (24.7;46.5) | 35 | 35.3 | (27.0;50.8) |
2005 | 91 | (62.4;120.9) | 53 | 57.8 | (43.8;85.0) | 27 | 29.5 | (22.3;43.3) | 27 | 29.5 | (22.3;43.3) | 34 | 37.1 | (28.1;54.5) |
2006 | 88 | (55.4;121.8) | 44 | 49.7 | (36.1;79.4) | 18 | 20.3 | (14.8;32.5) | 14 | 15.8 | (11.5;25.3) | 30 | 33.9 | (24.6;54.2) |
Place of birth | ||||||||||||||
France | 152 | (100.3;204.9) | 86 | 56.4 | (42.0;85.7) | 37 | 24.2 | (18.1;36.9) | 47 | 30.8 | (22.9;46.8) | 55 | 36.0 | (26.8;54.8) |
Foreign country | 234 | (158.9;309.9) | 130 | 55.5 | (42.0;81.8) | 73 | 31.1 | (23.6;45.9) | 54 | 23.0 | (17.4;34.0) | 74 | 31.6 | (23.9;46.6) |
Region of diagnosis | ||||||||||||||
Paris area | 198 | (154.7;241.4) | 139 | 70.2 | (57.6;89.9) | 79 | 39.9 | (32.7;51.1) | 79 | 39.9 | (32.7;51.1) | 82 | 41.4 | (34.0;53.0) |
Other regions | 188 | (101.0;276.8) | 77 | 40.8 | (27.8;76.2) | 31 | 16.4 | (11.2;30.7) | 22 | 11.6 | (7.9;21.8) | 47 | 24.9 | (17.0;46.5) |
Total | 387 | (271;503) | 216 | 55.8 | (42.9;79.7) | 110 | 28.4 | (21.9;40.1) | 101 | 26.1 | (20.1;37.3) | 129 | 33.3 | (25.6;47.6) |